95 results for pharmaceuticals
Filter results:
Article
Liquid Gold
Article
Areas of growth
Article
High on Drugs
Radio
The Briefing - Wednesday 29 April
29 April 2020
Will Germany introduce new lockdown restrictions to curb coronavirus? Plus: the CEO of Swiss pharmaceutical giant Novartis on fighting the pandemic, China’s plans for its parliament and physical distancing in Lithuania.
Radio
The Chiefs - Vas Narasimhan
13 April 2021
Monocle’s editorial director, Tyler Brûlé, is joined by Vas Narasimhan, CEO of Swiss pharmaceutical giant Novartis. One year on from their first discussion on ‘The Chiefs’, they assess the roadmap ahead, from vaccine rol…
Radio
The Curator - Monocle Radio highlights
1 October 2023
A selection of the best interviews on Monocle Radio this week, covering topics including the book collection of late Rolling Stones drummer Charlie Watts to a Brazilian pharmaceutical company expanding to the UK. Plus:…
Radio
The Bulletin with UBS - Healthcare and pharma after the pandemic
27 April 2020
What might be the enduring impact of the pandemic on healthcare delivery? Our panel discusses whether the digitisation of the space will accelerate further. We’ll also look at diagnostics, telemedicine and pharmaceuticals…
Radio
The Entrepreneurs - Eureka 211: SkyCell
21 August 2020
Richard Ettl is co-founder and CEO of SkyCell, a Swiss company that makes smart pharmaceutical containers used in the transport of highly sensitive treatments and vaccines. Along with sealed, temperature-regulated contai…
Article
Healthy balance
Article
Healthy trade
Radio
The Foreign Desk - America’s opioid crisis: a turning point?
31 August 2019
A judge in Oklahoma this week ruled that pharmaceutical giant Johnson & Johnson has to pay $572m for its part in the state’s opioid crisis. The firm is far from the only company embroiled in this ongoing and devastating…
Radio
The Chiefs - Vas Narasimhan
8 May 2020
Monocle’s editor in chief, Tyler Brûlé, joins some of the world’s leading business figures to ask how we get to the other side of the crisis – and what that might look like. First up is Vas Narasimhan, CEO of Swiss pharm…